The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19

Lan Shen(Shanghai Chest Hospital), Ning Zhou(Tongji Hospital), Heng Ge(Fujian Medical University), Jingjin Jin(Tongji Hospital), Eric D. Peterson(The University of Texas Southwestern Medical Center), Xiulan Liu(Tongji Hospital), Yi Liu(Wenzhou Medical University), Li Wang(Cleveland Clinic), Ying Xiao(Sun Yat-sen University), Dong Liu(Affiliated Hospital of Southwest Medical University), Ben He(Shanghai Chest Hospital), Dao Wen Wang(Tongji Hospital), Lin Qiu(Ministry of Ecology and Environment), Hengye Huang(Shanghai Jiao Tong University)
Cardiovascular Drugs and Therapy
January 4, 2021
10.1007/s10557-020-07133-3
Cited by 30

Related Papers

An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Circulation|2011|1.8k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Journal of the American College of Cardiology|2011|914
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
|JAMA|2013|869
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580